Diagnos (TSXV-ADK) (OTCQB-DGNOF), a leader in early detection of critical health issues, announces today the signing of a 2-month pilot with Hospital Oftalmológico Buena Vista Sinaloa, the largest ophthalmological hospital in Sinaloa State, Mexico. In Mexico there are 18 million diabetics with a 23% prevalence in people of 20 years or more; the seriousness of these cases is… Continue reading Diagnos $ADK $DGNOF Announces Pilot with Sinaloa Hospital
Tag: diabetes
Diagnos $ADK IRIS, a New Look #Vision Group Company, Teams up with Diagnos in a Multi-Year Agreement to Implement #AI #Technology with Support from INVEST-AI Program
Diagnos Inc. (TSX Venture: ADK) (OTCQB: DGNOF) (FRA: 4D4A), a leader in early detection of critical health issues, is pleased to announce the signing of a multi-year agreement with IRIS The Visual Group (1990) Inc. (“IRIS”), creating a world leading platform launch for the deployment and enhancement of Artificial Intelligence (“AI”) based tests, screening for… Continue reading Diagnos $ADK IRIS, a New Look #Vision Group Company, Teams up with Diagnos in a Multi-Year Agreement to Implement #AI #Technology with Support from INVEST-AI Program
Diagnos Inc. $ADK $DGNOF #Interview with InvestorIntel – #AI #Healthcare #Technology for #Diabetic #BlindnessPrevention
Diagnos Inc. $ADK $DGNOF #AI #healthcare #technology #diabetics #blindness #StrokePrevention Interview: https://youtu.be/B7elDQ7bgb4 InvestorIntel Interview with Andre Larente, President of Diagnos Inc.
Diagnos $ADK $DGNOF Enters into Exclusive Distribution Agreement to Access Massive Global Healthcare Market in DACH Countries and Central Europe of Over 140 Million People
Diagnos Inc. TSXV-ADK OTCQB: DGNOF a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces today the signing of an exclusive distribution agreement with Diagnos Europe GmbH (“Diagnos Europe”), a new partner for DIAGNOS to tackle the strategically important DACH countries in the European… Continue reading Diagnos $ADK $DGNOF Enters into Exclusive Distribution Agreement to Access Massive Global Healthcare Market in DACH Countries and Central Europe of Over 140 Million People
@Diagnos $ADK $DGNOF Uses #AI and #Telemedicine to Scan your #Eye for #Health Issues in 16 Countries
In a world where companies toss the term ‘artificial intelligence’ around whenever the office intern figures out how to get a spreadsheet pie chart to update automatically, it’s nice to see a company utilizing actual AI and machine learning in a manner that involves actual intelligence and learning. Diagnos (ADK.V) is a health tech deal… Continue reading @Diagnos $ADK $DGNOF Uses #AI and #Telemedicine to Scan your #Eye for #Health Issues in 16 Countries
Diagnos Inc. $ADK and the 3rd Largest #Optical Retailer in Costa Rica Piloting CARA and its #Telemedicine #Technology
Diagnos Inc. $ADK and the 3rd Largest #optical Retailer in Costa Rica Piloting CARA and its #telemedicine #technology #Healthcare #diabetes #retinaldisease #AI #artificialintelligence #Hypertension #stroke #deeplearning https://www.globenewswire.com/news-release/2021/03/04/2187355/0/en/DIAGNOS-and-the-third-largest-optical-retailer-in-Costa-Rica-Piloting-CARA-and-its-Telemedicine-technology.html Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based… Continue reading Diagnos Inc. $ADK and the 3rd Largest #Optical Retailer in Costa Rica Piloting CARA and its #Telemedicine #Technology
Diagnos Inc. $ADK AI Image-Based Diagnosis – Commercializing their CARA #Technology
Expanding globally in the AI image based diagnosis sector, Diagnos is actively commercializing their CARA technology. Diagnos TSXV-ADK is an AI health care company using non-invasive scanning technology done through the eyeball to detect retinal diabetes and hypertension. They are FDA approved, ISO certified and Health Canada approved. https://investorintel.com/markets/biotech-healthcare/biotech-intel/expanding-globally-in-the-ai-image-based-diagnosis-sector-diagnos-is-actively-commercializing-their-cara-technology/